US Patent Issued to SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) on Dec. 30 for "Antibody binding to human CD38, preparation method thereof, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,528, issued on Dec. 30, was assigned to SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) Co. LTD. (Shanghai).

"Antibody binding to human CD38, preparation method thereof, and use thereof" was invented by Wei Guo (Shanghai), Jie Zhao (Shanghai), Le Zhao (Shanghai), Qingcheng Liu (Shanghai), Jianhe Chen (Shanghai), Haomin Huang (Shanghai) and Zhenping Zhu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "An antibody or an antigen-binding fragment thereof that binds to human CD38. The antibody or the antigen-binding fragment thereof can effectively bind to human CD38 and is applied to preparing a drug for treating diseases having strong CD38 expressio...